These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17889477)

  • 1. HPLC method for the pharmacokinetics and tissue distribution of taspine solution and taspine liposome after intravenous administrations to mice.
    Lu W; He LC; Zeng XM
    J Pharm Biomed Anal; 2008 Jan; 46(1):170-6. PubMed ID: 17889477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
    Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
    Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and pharmacokinetics of nimodipine-loaded liposomes.
    Wang Z; Deng Y; Zhang X; Wang T; Wu F
    J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice.
    Lukka PB; Paxton JW; Kestell P; Baguley BC
    Cancer Chemother Pharmacol; 2010 May; 65(6):1145-52. PubMed ID: 19774378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and tissue distribution of imatinib in a liposome formulation after intravenous bolus dose to mice.
    Moo KS; Radhakrishnan S; Teoh M; Narayanan P; Bukhari NI; Segarra I
    Yao Xue Xue Bao; 2010 Jul; 45(7):901-8. PubMed ID: 20931790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPLC study of pharmacokinetics and tissue distribution of morroniside in rats.
    Li X; Wang Q; Zhang X; Sheng X; Zhou Y; Li M; Jing X; Li D; Zhang L
    J Pharm Biomed Anal; 2007 Oct; 45(2):349-55. PubMed ID: 17596900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics.
    Hao X; Cheng G; Sun J; Zou M; Yu J; Zhang S; Cui F
    J Pharm Biomed Anal; 2005 Jun; 38(2):360-3. PubMed ID: 15925232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced distribution and extended elimination of glycyrrhetinic acid in mice liver by mPEG-PLA modified (mPEGylated) liposome.
    Li J; Yu H; Li S; Wang GJ
    J Pharm Biomed Anal; 2010 Apr; 51(5):1147-53. PubMed ID: 20005656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailabilty and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration.
    Li HL; Zhang WD; Zhang C; Liu RH; Wang XW; Wang XL; Zhu JB; Chen CL
    J Pharm Biomed Anal; 2006 Jun; 41(4):1342-6. PubMed ID: 16644173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of novel inhibitors of androgen synthesis after intravenous administration in mice.
    Nnane IP; Njar VC; Brodie AM
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):519-24. PubMed ID: 12715204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.
    Boinpally RR; Polin L; Zhou SL; Jasti BR; Wiegand RA; White K; Kushner J; Horwitz JP; Corbett TH; Parchment RE
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):25-33. PubMed ID: 12739061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of CPU0213, a novel endothelin receptor antagonist, after intravenous administration in mice.
    Guan L; Feng Y; Ji M; Dai DZ
    Acta Pharmacol Sin; 2006 Mar; 27(3):367-71. PubMed ID: 16490175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice.
    Chaves JS; Leal PC; Pianowisky L; Calixto JB
    Planta Med; 2008 Nov; 74(14):1678-83. PubMed ID: 18951339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice.
    Lu W; He LC; Wang CH; Li YH; Zhang SQ
    Int J Biol Macromol; 2008 Oct; 43(3):320-4. PubMed ID: 18619484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interconversion and tissue distribution of pentoxifylline and lisofylline in mice.
    Wyska E; Pekala E; Szymura-Oleksiak J
    Chirality; 2006 Aug; 18(8):644-51. PubMed ID: 16721727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of additives on absorption of Coptis chinensis total alkaloids and pharmacokinetics in mice].
    Li Y; Ye X; Li X; Chu H; Liu G; Zhu Y; Chen X; Zhou J; Li X
    Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(3):344-8. PubMed ID: 19445164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.